{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/836204111",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/156218529"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#836204111",
  "code": "3B21.0",
  "source": "http://id.who.int/icd/entity/836204111",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Haemorrhage due to thrombin inhibitor other than heparin"
  },
  "definition": {
    "@language": "en",
    "@value": "A disease caused by any thrombin inhibitors other than heparin that affects normal coagulation of the blood. This disease is characterised by inability of the blood to coagulate leading to bleeding. Confirmation is by identification of thrombin inhibitors in a blood sample."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Haemorrhage due to thrombin inhibitor other than heparin"
      }
    }
  ]
}